Clinical Trials
134 trialsSCEMAM
University of Pittsburgh
METAL3
Institut Claudius Regaud
PHACS
Institut Claudius Regaud
OXYTAM
Institut Claudius Regaud
MIRHO
Institut Claudius Regaud
A Randomized Trial Evaluating Personalized vs Guideline-based Well Follow-up Strategies for Patients With Early-stage Breast Cancer
Ottawa Hospital Research Institute
Clinical and P
Beni-Suef University
CHIMTEP
Centre Oscar Lambret
A Study of Serum Folate Levels in Patients Treated With Olaparib
Rush University Medical Center
Study of Nerve Block Pain Management in Patients Undergoing a Double Mastectomy With Immediate Reconstruction
Memorial Sloan Kettering Cancer Center
REaCT-ZOL
Ottawa Hospital Research Institute
Evaluating the Dose Timing (Morning vs Evening) of Endocrine Therapy and Its Effects on Tolerability and Compliance
Ottawa Hospital Research Institute
OTT 15-05
Ottawa Hospital Research Institute
Utilizing MyChart to Assess the Effectiveness of Interventions for Vasomotor Symptoms: A Feasibility Study
Ottawa Hospital Research Institute
Chlorhydrate of Ropivacaine and Breast Cancer Surgery
Institut Curie
Dexmedetomidine-esketamine Combined Nasal Administration and Perioperative Sleep Quality
Peking University First Hospital
VSMART
University of Miami
Quantitative Subharmonic Breast Imaging
Thomas Jefferson University
breast cancer
Sohag University
A Randomized, Multicenter Pragmatic Trial Comparing Bone Pain From a Single Dose of Pegfilgrastim to 5 Doses of Daily Filgrastim in Breast Cancer Patients Receiving Neoadjuvant/Adjuvant Chemotherapy
Ottawa Hospital Research Institute
SOLI
AstraZeneca
Use of Microporous Polysaccharide Hemispheres in Breast Cancer Patients Undergoing Mastectomy
Fundación para la Investigación del Hospital Clínico de Valencia
Use of Topical Olive Oil Cream for Prophylaxis Against Acute Radiodermatitis in Breast Cancer Patients
Cairo University
Brovale
Erasme University Hospital
PADMA
GBG Forschungs GmbH
ARTISS
Mid and South Essex NHS Foundation Trust
A Study of Abemaciclib in Indian Women With Advanced Breast Cancer
Eli Lilly and Company
Study Comparing Full-dose Radiotherapy Versus Reduced Dose in the Management of Bone Metastasis in Patients With Breast Cancer Receiving Zoledronic Acid
Novartis
IGF Level in Breast Cancer Patients Treated With Metformin
Beni-Suef University
Long-term Outcomes of Breast Cancer Patients After Wound Infiltration Analgesia
Osijek University Hospital
Pamidronate Administration in Breast Cancer Patients With Bone Metastases
Spanish Breast Cancer Research Group
Incidence of Chemotherapy-Induced Nausea and Vomiting Associated With Docetaxel-Cyclophosphamide in Early Breast Cancer.
Spanish Breast Cancer Research Group
Maintenance Treatment With Liposomal Doxorubicin (Caelyx) in Metastatic Breast Cancer Patients
Spanish Breast Cancer Research Group
The Ultrasound-guided Multiple-injection Costotransverse Block for Mastectomy and Primary Reconstructive Surgery.
Zealand University Hospital
The Effect of Octreotide on Wound Drainage After Mastectomy
University College Hospital, Ibadan
CAN
Uppsala University
RCT of Fixed vs Titrated Letrozole in Breast Cancer Patient Undergoing IVF
Weill Medical College of Cornell University
ELEGANT
Ruijin Hospital
Safety and Efficacy of Trastuzumab as Part of Breast Cancer Treatment Regimen
Hoffmann-La Roche
REaCT-RETT
Ottawa Hospital Research Institute
Palbociclib In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR+, HER2- Advanced Breast Cancer
Pfizer
VAPOR-C
Peter MacCallum Cancer Centre, Australia
VIBRA
Hospital Clinic of Barcelona
ESP in Breast Surgery Due to Cancer
Medical University of Lublin
Aromasin® Interventional Study Of Early Invasive Breast Cancer Patients In China
Pfizer
Wound Infections in Breast Cancer Surgery After Preoperative Skin Preparation With Chlorhexidine vs. Povidone-iodine
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
A Single Arm, Tolerability and Safety Phase IV Study of Fulvestrant(Faslodex® ) as 2nd Line and Later Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
AstraZeneca
Immunogenicity Assessment of Peg-filgrastim vs. Neulasta® as Adjunct to Chemotherapy in Patients With Breast Cancer
Lupin Ltd.
REAL
Novartis
A Study of Trastuzumab Emtansine in Indian Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Unresectable Locally Advanced or Metastatic Breast Cancer Who Have Received Prior Treatment With Trastuzumab and a Taxane
Hoffmann-La Roche